Zn(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on prostate cancer incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“We did not find statistically significant associations for zinc supplement and risk of overall, localized, low- or intermediate-grade prostate cancer.”
Quoted verbatim from Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study.. - Study
- cohort
- Dose
- self-reported supplemental zinc use, categories 1-24, 25-74 and >=75 mg/day, and duration up to >=15 years
- Population
- Men in the Health Professionals Follow-up Study (47,240 men without prior cancer), supplemental zinc use compared with never-users, median follow-up 28.3 years; overall prostate cancer, localized and low- or intermediate-grade subtypes
Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study.2022PMID:36326979Permalink
Keep reading
- Everything the graph holds on Zn(2+)
- Every compound studied against Prostate cancer incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5MDZ2E3FNSDWM1WD4Q6NFW2